BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28485543)

  • 21. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct anti-cancer effect of oncostatin M on chondrosarcoma.
    David E; Guihard P; Brounais B; Riet A; Charrier C; Battaglia S; Gouin F; Ponsolle S; Bot RL; Richards CD; Heymann D; Rédini F; Blanchard F
    Int J Cancer; 2011 Apr; 128(8):1822-35. PubMed ID: 21344373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.
    Shinohara N; Maeda S; Yahiro Y; Sakuma D; Matsuyama K; Imamura K; Kawamura I; Setoguchi T; Ishidou Y; Nagano S; Komiya S
    Sci Rep; 2017 Oct; 7(1):13494. PubMed ID: 29044189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
    Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
    Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Andrographolide sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo.
    Lin HH; Shi MD; Tseng HC; Chen JH
    Toxicol Sci; 2014 May; 139(1):108-20. PubMed ID: 24563380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Andrographolide causes p53-independent HCC cell death through p62 accumulation and impaired DNA damage repair.
    Li XY; Cui X; Xie CQ; Wu Y; Song T; He JD; Feng J; Cui QR; Bin JL; Li QY; Xiao C; Deng JH; Lu GD; Zhou J
    Phytomedicine; 2023 Dec; 121():155089. PubMed ID: 37738908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATM-p53 pathway causes G2/M arrest, but represses apoptosis in pseudolaric acid B-treated HeLa cells.
    Yao G; Qi M; Ji X; Fan S; Xu L; Hayashi T; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2014 Sep; 558():51-60. PubMed ID: 24929187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Andrographolide inhibits hepatoma cells growth and affects the expression of cell cycle related proteins.
    Shen KK; Liu TY; Xu C; Ji LL; Wang ZT
    Yao Xue Xue Bao; 2009 Sep; 44(9):973-9. PubMed ID: 20055171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epigenetic regulation of SOX9 by miR-145 in human chondrosarcoma.
    Mak IW; Singh S; Turcotte R; Ghert M
    J Cell Biochem; 2015 Jan; 116(1):37-44. PubMed ID: 25145279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Andrographolide inhibits proliferation and induces cell cycle arrest and apoptosis in human melanoma cells.
    Liu G; Chu H
    Oncol Lett; 2018 Apr; 15(4):5301-5305. PubMed ID: 29552170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
    Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
    Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
    Nakagawa M; Nakatani F; Matsunaga H; Seki T; Endo M; Ogawara Y; Machida Y; Katsumoto T; Yamagata K; Hattori A; Fujita S; Aikawa Y; Ishikawa T; Soga T; Kawai A; Chuman H; Yokoyama N; Fukushima S; Yahiro K; Kimura A; Shimada E; Hirose T; Fujiwara T; Setsu N; Matsumoto Y; Iwamoto Y; Nakashima Y; Kitabayashi I
    Oncogene; 2019 Oct; 38(42):6835-6849. PubMed ID: 31406254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
    Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
    Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methyl Sartortuoate Inhibits Colon Cancer Cell Growth by Inducing Apoptosis and G2/M-Phase Arrest.
    Lan Q; Li S; Lai W; Xu H; Zhang Y; Zeng Y; Lan W; Chu Z
    Int J Mol Sci; 2015 Aug; 16(8):19401-18. PubMed ID: 26287184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BMPR2 inhibition induced apoptosis and autophagy via destabilization of XIAP in human chondrosarcoma cells.
    Jiao G; Guo W; Ren T; Lu Q; Sun Y; Liang W; Ren C; Yang K; Sun K
    Cell Death Dis; 2014 Dec; 5(12):e1571. PubMed ID: 25501832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
    Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
    Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
    Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
    Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway.
    Lu X; Tang X; Guo W; Ren T; Zhao H
    J Surg Oncol; 2010 Dec; 102(7):821-6. PubMed ID: 20812347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells.
    Zhou J; Hu SE; Tan SH; Cao R; Chen Y; Xia D; Zhu X; Yang XF; Ong CN; Shen HM
    Autophagy; 2012 Mar; 8(3):338-49. PubMed ID: 22302005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.